A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy

BACKGROUND: Triple negative breast cancers (TNBCs) have a poor prognosis and are not amenable to endocrine- or HER2-targeted therapies. The malignant and invasive feature of TNBCs is correlated with its high cancer stem cell population. Recent results from us and others have unveiled an oncogenic ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhuan, Feng, Zhiwei, Hu, Dong, Yang, Peng, Gur, Mert, Bahar, Ivet, Cristofanilli, Massimo, Gradishar, William J., Xie, Xiang-qun, Wan, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604046/
https://www.ncbi.nlm.nih.gov/pubmed/31101597
http://dx.doi.org/10.1016/j.ebiom.2019.05.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604046/
https://www.ncbi.nlm.nih.gov/pubmed/31101597
http://dx.doi.org/10.1016/j.ebiom.2019.05.011

Ejemplares similares